6Lake FR, Tribe AE, McAleer R, et al. Mixed allergic bronchopulmonary fungal disease due to pseudallescheria boydi and aspergillus. Thorax, 1990, 45:489--492. 被引量：1
7Wheat LJ, Goldman M, Sarosi G. State of the art review of pulmonary fungal infections. Semin Respir Infect, 2002, 17:158- 181. 被引量：1
8Waterer G W, Rello J, Wunderink R G. management of communityacquired pneumonia in adults [ J]. Am J Respir Crit Care Med, 2011,183:157 - 164. 被引量：1
9Christ-Crain M, Stoiz D, Bingsser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial[ J]. Am J Respir Crit Care Med,2006,174:84 - 93. 被引量：1
3Ribeiro CF, Ferrari GF, Fioretto JR. Antibiotic treatment schemes for very severe community acquired pneumonia in children:a ran- domized clinical study[J. Rev Panam Salud Publica,2011,29(6) : 444-450. 被引量：1
4Viasus D, Garcia-Vidal C, Gudiol F, et al. Statins for community- acquired pneumonia., current state of the science[J]. Eur J Clin Microbiol Infect Dis,2010,29(2)143-152. 被引量：1
5Cho MC,Kim H,An D,et al. Comparison of sputum and nasopha- ryngeal swab specimens for molecular diagnosis of Mycoplasma pneumoniae,Chlamydophila pneumoniae, and Legionella pneumo- phila[J]. Ann Lab Med,2012,32(2):133 138. 被引量：1
